HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 295/5/H1974    most recent 00265.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by do Carmo, J. M. Articles by da Silva, A. A. Search for Related Content PubMed PubMed Citation Articles by do Carmo, J. M. Articles by da Silva, A. A.

Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats

Department of Physiology and Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Mississippi

Submitted 12 March 2008 ; accepted in final form 5 September 2008

This study tested whether leptin restores sympathetic-vagal balance, heart rate (HR) variability, and cardiac baroreflex sensitivity (BRS) in streptozotocin (STZ)-induced diabetes. Sprague-Dawley rats were instrumented with arterial and venous catheters, and a cannula was placed in the lateral ventricle for intracerebroventricular (ICV) leptin infusion. Blood pressure (BP) and HR were monitored by telemetry. BRS and HR variability were estimated by linear regression between HR and BP responses to phenylephrine or sodium nitroprusside and autoregressive spectral analysis. Measurements were made during control period, 7 days after induction of diabetes, and 7 days after ICV leptin infusion. STZ diabetes was associated with hyperglycemia (422 ± 17 mg/dl) and bradycardia (–79 ± 4 beats/min). Leptin decreased glucose levels (165 ± 16 mg/dl) and raised HR to control values (303 ± 10 to 389 ± 10 beats/min). Intrinsic HR (IHR) and chronotropic responses to a full-blocking dose of propranolol and atropine were reduced during diabetes (260 ± 7 vs. 316 ± 6, –19 ± 2 vs. –43 ± 6, and 39 ± 3 vs. 68 ± 8 beats/min), and leptin treatment restored these variables to normal (300 ± 7, –68 ± 10, and 71 ± 8 beats/min). Leptin normalized BRS (bradycardia, –2.6 ± 0.3, –1.7 ± 0.2, and –3.0 ± 0.5; and tachycardia, –3.2 ± 0.4, –1.9 ± 0.3, and –3.4 ± 0.3 beats·min^–1·mmHg^–1 for control, diabetes, and leptin) and HR variability (23 ± 4 to 11 ± 1.5 ms²). Chronic glucose infusion to maintain hyperglycemia during leptin infusion did not alter the effect of leptin on IHR but abolished the improved BRS. These results show rapid impairment of autonomic nervous system control of HR after the induction of diabetes and that central nervous system actions of leptin can abolish the hyperglycemia as well as the altered IHR and BRS in STZ-induced diabetes.

diabetes mellitus; autonomic nervous system; heart rate variability; streptozotocin

This article has been cited by other articles:

				A. C. Arnold, H. A. Shaltout, P. E. Gallagher, and D. I. Diz Leptin Impairs Cardiovagal Baroreflex Function at the Level of the Solitary Tract Nucleus Hypertension, November 1, 2009; 54(5): 1001 - 1008. [Abstract] [Full Text] [PDF]

				A. A. da Silva, J. M. do Carmo, J. N. Freeman, L. S. Tallam, and J. E. Hall A Functional Melanocortin System May Be Required for Chronic CNS-Mediated Antidiabetic and Cardiovascular Actions of Leptin Diabetes, August 1, 2009; 58(8): 1749 - 1756. [Abstract] [Full Text] [PDF]

				H. Xia, Y. Feng, T. D. Obr, P. J. Hickman, and E. Lazartigues Angiotensin II Type 1 Receptor-Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice Hypertension, February 1, 2009; 53(2): 210 - 216. [Abstract] [Full Text] [PDF]